KRAS and colorectal carcinoma: Specifically, BYL719 downregulated cyclin D1 protein levels in CRC cells with KRAS mutations as well as pBad (Ser112), pBad (Ser136) and XIAP in KRAS/PIK3CA mutant CRC cells, further validating the siRNA data.